Provided by Tiger Trade Technology Pte. Ltd.

Catabasis Pharmaceuticals

8.54
0.0000
Volume:- -
Turnover:- -
Market Cap:109.52M
PE:-0.16
High:8.54
Open:8.54
Low:8.54
Close:8.54
52wk High:47.82
52wk Low:6.31
Shares:12.82M
Float Shares:7.30M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-54.3943
EPS(LYR):-12.1952
ROE:-210.26%
ROA:-20.32%
PB:2.95
PE(LYR):-0.70

Loading ...

Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2020

Major Issues Report

8-K - Current report
Sep 21, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 12, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 10, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 30, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Dec 19, 2019

Major Issues Report

Current report, item 5.02
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 16, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 23, 2019

Major Issues Report

Current report, item 5.02
Sep 13, 2019

Major Issues Report

Current report, item 1.01